Dental technology company Align Technology (NASDAQ: ALGN) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 4.3% year on year to $1.06 billion. On the other hand, next quarter’s revenue guidance of $1.01 billion was less impressive, coming in 1.3% below analysts’ estimates. Its non-GAAP profit of $2.64 per share was 1.7% above analysts’ consensus estimates.
Is now the time to buy ALGN? Find out in our full research report (it’s free for active Edge members).
Align Technology (ALGN) Q2 CY2026 Highlights:
- Revenue: $1.06 billion vs analyst estimates of $1.05 billion (4.3% year-on-year growth, in line)
- Adjusted EPS: $2.64 vs analyst estimates of $2.60 (1.7% beat)
- Adjusted Operating Income: $241.7 million vs analyst estimates of $230.6 million (22.9% margin, 4.8% beat)
- Revenue Guidance for Q3 CY2026 is $1.01 billion at the midpoint, below analyst estimates of $1.02 billion
- Operating Margin: 14.6%, down from 16.1% in the same quarter last year
- Sales Volumes were up 7.4% year on year
- Market Capitalization: $12.9 billion
StockStory’s Take
Align Technology’s second quarter results were shaped by growth in Clear Aligner volumes and stable North American performance, with international markets such as APAC and EMEA driving double-digit expansion. CEO Joe Hogan attributed the quarter’s momentum to broader adoption across orthodontists and GP dentists, as well as product enhancements supporting clinical confidence and practice productivity. Management acknowledged persistent softness in the Systems and Services segment, citing ongoing shifts toward lower-cost scanner models and flexible acquisition programs.
Looking ahead, management’s guidance reflects caution due to a continued mix shift toward lower-priced scanners and flexible acquisition models, particularly in the Systems and Services segment. CFO John Morici stated, “We are intentionally evolving our scanner business to expand access, but this will pressure reported revenue and profitability in the near term.” The company is also focused on cost discipline, margin improvement, and further expansion of Clear Aligner adoption, while monitoring macroeconomic volatility and regional demand patterns.
Key Insights from Management’s Remarks
Management credited the quarter’s growth to robust Clear Aligner adoption and recurring digital workflows, while noting that lower scanner prices and a deliberate shift to rentals and leases weighed on revenues and margins.
-
International Clear Aligner momentum: Double-digit volume growth in APAC, EMEA, and Latin America offset stable performance in North America. CEO Joe Hogan highlighted strong uptake across both adult and teen patient segments, with DSOs (Dental Service Organizations) in North America continuing to expand volumes.
-
Systems and Services headwinds: The company experienced ongoing weakness in its capital equipment market, driven by dentists’ and orthodontists’ preference for lower-priced scanners and flexible acquisition models such as rentals and leases. Management described this as an intentional pivot to broaden customer access to digital workflows, despite near-term revenue and profitability pressure.
-
Product innovation and digital workflow: Align introduced new features to its digital platform, including expanded capabilities for the Invisalign Palatal Expander and 3D-printed attachments, aimed at enhancing treatment planning and efficiency. These product enhancements were showcased at the 2026 Invisalign Ortho Summit, highlighting the company’s focus on integrating diagnostics, planning, and delivery.
-
Financing solutions and adoption programs: Increased investment in patient financing and doctor subscription offerings supported adoption in both orthodontist and GP dentist channels. Management cited positive early traction for these initiatives, particularly in converting “reluctant” patients and driving higher utilization rates.
-
Strategic governance and operational review: Align announced the addition of three new independent directors and launched a comprehensive review of its strategic and operating model, following discussions with Elliott Management. The review aims to enhance commercial execution, resource optimization, and long-term profitability.
Drivers of Future Performance
Align expects future performance to be shaped by further adoption of Clear Aligners, the ongoing shift in scanner business models, and continued margin discipline amid macroeconomic and competitive pressures.
-
Global Clear Aligner adoption: Management expects sustained growth from international markets, especially APAC and EMEA, with continued strength in DSOs and expanded patient financing. The rollout of new digital workflow tools and subscription offerings is expected to support broader adoption, though North American retail remains a priority area for improvement.
-
Scanner business model transition: The deliberate move toward lower-priced scanner configurations and increased leasing/rental options is designed to expand access and grow the installed base. While this supports long-term recurring revenues, management cautions it will weigh on upfront revenue and margins, with mix effects persisting into 2027.
-
Margin improvement initiatives: Align is conducting a strategic review to identify opportunities for cost optimization and operating leverage. CFO John Morici indicated that gross margin expansion is primarily being driven by lower manufacturing costs and product mix, while operating expense discipline is another focus for delivering targeted margin gains.
Catalysts in Upcoming Quarters
In the coming quarters, our analysts will focus on (1) the pace of Clear Aligner adoption in international markets and any signs of recovery in North American retail, (2) progress in shifting scanner placements toward recurring revenue models and the impact on reported margins, and (3) the outcome of Align’s strategic and operating model review, including cost discipline and board changes. Updates on digital workflow innovation and patient financing traction will also be key indicators of future growth.
Align Technology currently trades at $174.67, in line with $174.48 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free).
High Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.
